Clinical Trial Update: Monoclonal Antibody Vaccine Therapy in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cancer [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating a monoclonal antibody vaccine therapy for ovarian epithelial, fallopian tube, and primary peritoneal cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• Monoclonal Antibody Vaccine Therapy

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Fallopian Tube Cancer, Ovarian Cancer | Phase 1 | Status: COMPLETED